Cargando…
Advances in metabolic disorders. Volume 5 /
Advances in Metabolic Disorders.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Burlington :
Elsevier Science,
1971.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn879550846 | ||
| 003 | OCoLC | ||
| 005 | 20231120111601.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 140510s1971 onc o 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d N$T |d OPELS |d OCLCF |d OCLCQ |d YDXCP |d OCLCQ |d UIU |d OCLCQ |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 907194911 | ||
| 020 | |a 9781483215471 |q (electronic bk.) | ||
| 020 | |a 1483215474 |q (electronic bk.) | ||
| 020 | |z 9780120273058 | ||
| 035 | |a (OCoLC)879550846 |z (OCoLC)907194911 | ||
| 050 | 4 | |a RC620 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.39 |2 22 |
| 245 | 0 | 0 | |a Advances in metabolic disorders. |n Volume 5 / |c edited by Rachmiel Levine and Rolf Luft. |
| 260 | |a Burlington : |b Elsevier Science, |c 1971. | ||
| 300 | |a 1 online resource (391 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Advances in Metabolic Disorders; Copyright Page; Table ofContents; Contributors; Contents of Previous Volumes; Chapter 1. Hypothalamic Control of the Secretion of Adenohypophysial Hormones; I. Introduction; II. Chemistry of the Hypothalamic Releasing Factors; III. Mechanisms of Action of the Hypothalamic Factors; IV. Conclusions; References; Chapter 2. Adrenocortical Control of Epinephrine Synthesis in Health and Disease; I. Introduction; II. Morphology of the Mammalian Adrenal Gland; III. Catecholamine Biosynthesis in Neurons and Chromaffin Cells. | |
| 505 | 8 | |a IV. Adrenocortical Control of Adrenomedullary FunctionV. PNMT Activity in the Brain; VI. The Adrenal Cortex and Epinephrine Synthesis in Nonmammalian Vertebrates; VII. Clinical Implications; ACKNOWLEDGMENTS; References; Chapter 3. The Relationship between Angiotensin and Aldosterone; I. The Renin-Angiotensin System in the Physiological Control of Aldosterone Secretion; II. Clinical Implications; III. Conclusions; ACKNOWLEDGMENTS; References; Chapter 4. The Metabolic Influence of Progestins; I. Introduction; II. Electrolyte Metabolism; III. Protein Metabolism; IV. Growth Hormone Secretion. | |
| 505 | 8 | |a V. Carbohydrate MetabolismVI. Fat Metabolism; VII. Respiratory Effects; VIII. The Influence of Synthetic Progestins on Electrolyte Metabolism; IX. The Effect of Synthetic Progestins on Protein Metabolism; References; Chapter 5. The Thymus Gland: Experimental and Clinical Studies of Its Role in the Development and Expression of Immune Functions; I. Introduction; II. Historical; III. Phylogenetic and Embryonic Development of the Thymus Gland; IV. Modern Concepts of Thymus Function Derived from Experimental Studies; V. Thymus Malfunction and Clinical Disorders; VI. Summary; References. | |
| 505 | 8 | |a Chapter 6. Control of Glucose Metabolism in the Human Fetus and Newborn InfantI. Introduction; II. Modification of Maternal Metabolism by the Conceptus; III. Placental Transport of Nutrients and Hormones; IV. Fetal Glucose Metabolism; V. The Newborn Infant: the Effects of Birth; VI. Effects of an Abnormal Intrauterine Environment on Neonatal Glucose Homeostasis; VII. Summary and Conclusions; ACKNOWLEDGMENTS; References; Chapter 7. Human Adipose Tissue Dynamics and Regulation; I. Introduction; II. Sampling Techniques; III. Morphology and Cell Composition; IV. Human Adipose Tissue Metabolism. | |
| 505 | 8 | |a V. Concluding RemarksReferences; Chapter 8. Coronary Disease and Carbohydrate and Fat Abnormalities; I. Introduction; II. Experimental Design; III. Results; IV. Discussion; V. Summary; References; Author Index; Subject Index. | |
| 520 | |a Advances in Metabolic Disorders. | ||
| 650 | 0 | |a Metabolism |x Disorders. | |
| 650 | 0 | |a Metabolism. | |
| 650 | 2 | |a Metabolic Diseases |0 (DNLM)D008659 | |
| 650 | 2 | |a Metabolism |0 (DNLM)D008660 | |
| 650 | 6 | |a Troubles du m�etabolisme. |0 (CaQQLa)201-0061163 | |
| 650 | 6 | |a M�etabolisme. |0 (CaQQLa)201-0062122 | |
| 650 | 7 | |a metabolism (biological concept) |2 aat |0 (CStmoGRI)aat300254909 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Metabolism |2 fast |0 (OCoLC)fst01017473 | |
| 650 | 7 | |a Metabolism |x Disorders |2 fast |0 (OCoLC)fst01017476 | |
| 700 | 1 | |a Levine, Rachmiel, |d 1910-1998, |e editor. | |
| 700 | 1 | |a Luft, Rolf, |d 1914- |e editor. | |
| 776 | 0 | 8 | |i Print version: |a Levine, Rachmiel. |t Advances in Metabolic Disorders. |d Burlington : Elsevier Science, 1971 |z 9781483215471 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780120273058 |z Texto completo |